文献速递血栓与止血

遗传性血栓性血小板减少性紫癜五例临床诊治分析及文献复习

[Clinical diagnosis and treatment of hereditary thrombocytopenia and purpura: a report of five cases and literature review].
PubMed 文献 · Zhonghua Xue Ye Xue Za Zhi · 2023-01-01

报道5例遗传性血栓性血小板减少性紫癜(cTTP)患者的临床表现和实验室检查特点,结合文献探讨其规范化诊治。患者发病年龄为1、9、12、19、31岁,主要表现血小板明显减少、贫血及神经系统受累,多被疑诊为免疫性血小板减少症;所有病例均检出ADAMTS13基因突变,治疗性和预防性血浆输注有效。结论认为cTTP临床表现异质性强、易误诊,ADAMTS13活性检测和基因突变分析是重要诊断依据,预防性血浆输注可有效控制疾病发作。

要点

  • 5例cTTP患者发病年龄为1、9、12、19、31岁,主要表现血小板明显减少、贫血及神经系统受累。
  • 既往多被疑诊为免疫性血小板减少症;2例女性因妊娠诱发,其他病例存在感染诱因。
  • 所有病例均检出ADAMTS13基因突变,治疗性和预防性血浆输注均有效。

核心结论

  • cTTP临床表现具有明显异质性,易被误诊而延误治疗。
  • ADAMTS13活性检测和ADAMTS13基因突变分析是诊断cTTP的重要依据。
  • 预防性血浆输注可有效控制疾病发作。

研究设计与样本

  • 对5例遗传性血栓性血小板减少性紫癜(cTTP)患者的临床资料进行报道并结合文献复习。
  • 收集发病年龄、疾病表现、个人史、家族史、误诊情况等临床资料。
  • 观察血浆输注疗效和器官功能评估等治疗结局。
  • 结合血浆ADAMTS13活性测定及ADAMTS13基因突变分析,探讨临床表现、治疗结局与基因突变间的内在联系。

主要发现

  • 5例患者中男1例、女4例,发病年龄分别为1、9、12、19、31岁。
  • 主要临床表现为血小板明显减少、贫血及神经系统受累表现;既往多被疑诊为免疫性血小板减少症。
  • 2例女性患者因妊娠诱发,其他病例存在感染诱因。
  • 所有病例均检出ADAMTS13基因突变,基因突变区域与患者临床表现及器官损伤程度之间存在内在联系。
  • 治疗性和预防性血浆输注是有效的治疗方法。

临床怎么用

  • 血浆ADAMTS13活性检测和ADAMTS13基因突变分析用于cTTP的诊断。
  • 治疗性血浆输注和预防性血浆输注用于cTTP的治疗与预防发作。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To report the clinical manifestations and laboratory features of five patients with congenital thrombotic thrombocytopenic purpura (cTTP) and explore its standardized clinical diagnosis and treatment along with a review of literature. Methods: Clinical data of patients, such as age of onset, disease manifestation, personal history, family history, and misdiagnosed disease, were collected. Treatment outcomes, therapeutic effects of plasma infusion, and organ function evaluation were observed. The relationship among the clinical manifestations, treatment outcomes, and ADAMTS13 gene mutation of patients with cTTP was analyzed. Additionally, detection of ADAMTS13 activity and analysis of ADAMTS13 gene mutation were explored. Results: The age of onset of cTTP was either in childhood or adulthood except in one case, which was at the age of 1. The primary manifestations were obvious thrombocytopenia, anemia, and different degrees of nervous system involvement. Most of the patients were initially suspected of having immune thrombocytopenia. Acute cTTP was induced by pregnancy and infection in two and one case, respectively. ADAMTS13 gene mutation was detected in all cases, and there was an inherent relationship between the mutation site, clinical manifestations, and degree of organ injury. Therapeutic or prophylactic plasma transfusion was effective for treating cTTP. Conclusions: The clinical manifestations of cTTP vary among individuals, resulting in frequent misdiagnosis that delays treatment. ADAMTS13 activity detection in plasma and ADAMTS13 gene mutation analysis are important bases to diagnose cTTP. Prophylactic plasma transfusion is vital to prevent the onset of the disease. 目的: 报道5例遗传性血栓性血小板减少性紫癜(cTTP)患者的临床表现及实验室检查特点,结合文献资料探讨cTTP的临床诊治方法。 方法: 分析患者发病年龄、疾病表现、个人史、家族史、误诊情况等临床资料,观察血浆输注疗效和器官功能评估等治疗结局;结合血浆ADAMTS13活性测定及ADAMTS13基因突变分析,探讨cTTP临床表现、治疗结局与ADAMTS13基因突变间的相互内在联系。 结果: 5例CTTP患者中男1例,女4例,发病年龄分别为1、9、12、19、31岁,主要临床表现为血小板明显减少、贫血及神经系统受累表现;既往多被疑诊为免疫性血小板减少症;2例女性患者因妊娠诱发,其他病例存在感染诱因。所有病例均检出ADAMTS13基因突变,基因突变区域与患者临床表现及器官损伤程度之间存在内在联系。治疗性和预防性血浆输注是有效的治疗方法。 结论: cTTP临床表现具有明显异质性,易被误诊而延误治疗。ADAMTS13活性检测和基因突变分析是重要诊断依据,预防性血浆输注可有效控制疾病发作。.

来源:Zhonghua Xue Ye Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Lyu XP, Yin J, Kong DQ, et al. [Clinical diagnosis and treatment of hereditary thrombocytopenia and purpura: a report of five cases and literature review]. Zhonghua Xue Ye Xue Za Zhi. 2023. PMID: 36987722. doi:10.3760/cma.j.issn.0253-2727.2023.01.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。